Related Experiment Video
Updated: Jun 22, 2026

Assays for the Degradation of Misfolded Proteins in Cells
Published on: August 28, 2016
REGgamma/PA28gamma proteasome activator interacts with PML and Chk2 and affects PML nuclear bodies number
Laura Zannini1, Giacomo Buscemi, Enrico Fontanella
1Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano 20133, Italy. laura.zannini@istitutotumori.mi.it
Abstract:
REGgamma (also called PA28gamma or PSME3) is a proteasome activator involved in the degradation of several proteins that regulate cell cycle and transcription. Recently, we demonstrated that this protein has a role also in the maintenance of chromosomal stability and in the response to spindle damaging agents. Here we report for the first time that REGgamma interacts with the promyelocytic leukemia protein (PML), accumulates in PML nuclear bodies (PML-NBs), but it does not play any role in normal or arsenic-induced PML degradation. However, REGgamma seems to regulate PML-NBs number, since its deficiency causes an increase in PML-NBs, which can be overcome by increased levels of SUMO1, and its overexpression has the opposite effect. We additionally found that REGgamma interacts with the DNA damage checkpoint kinase Chk2, whose presence is necessary for the increase of PML-NBs induced by REGgamma deficiency, and that REGgamma depletion resulted in a partial restoration of PML-NBs in APL derived cells. Altogether, these results underline a new role for REGgamma in the control and regulation of PML subnuclear structures.
Insights
REGgamma, a proteasome activator, interacts with PML and regulates PML nuclear bodies (PML-NBs). Its deficiency increases PML-NBs, while overexpression decreases them, revealing a new role in controlling these structures.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- REGgamma (PSME3) is a proteasome activator.
- REGgamma is involved in cell cycle, transcription, and chromosomal stability.
- Its role in nuclear bodies was previously unknown.
Purpose of the Study:
- To investigate the interaction between REGgamma and PML.
- To determine REGgamma's role in PML nuclear body (PML-NB) regulation.
- To elucidate REGgamma's function in DNA damage response pathways.
Main Methods:
- Co-immunoprecipitation assays to detect protein interactions.
- Immunofluorescence microscopy to visualize PML-NBs.
- Cellular assays to assess protein degradation and SUMOylation.
- Analysis of cells with altered REGgamma expression or deficiency.
Main Results:
- REGgamma interacts with PML and localizes to PML-NBs.
- REGgamma does not affect PML degradation but regulates PML-NB number.
- REGgamma deficiency increases PML-NBs, modulated by SUMO1 and Chk2.
- REGgamma overexpression decreases PML-NBs.
Conclusions:
- REGgamma plays a novel role in regulating PML nuclear body formation and number.
- REGgamma's interaction with PML and Chk2 is crucial for this regulation.
- These findings offer new insights into the control of subnuclear structures in cellular processes.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Regulation of Nuclear Protein Sorting
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway

